EBM BLS: Adding tirzepatide to long-acting insulin is superior to adding mealtime insulin for type 2 diabetes mellitus

Stephen Fuest, Venu Ganipisetti, John M. Cunningham

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)2878-2879
Number of pages2
JournalJournal of General Internal Medicine
Volume39
Issue number14
DOIs
StatePublished - Nov 2024

ASJC Scopus subject areas

  • Internal Medicine

Cite this